On August 13, 2026, Lorence H. Kim, M.D., resigned from the Board of Directors effective immediately following a quarterly board meeting. His departure is linked to his appointment as Chief Financial Officer at Commonwealth Fusion Systems, Inc., requiring additional professional commitment. Dr. Kim confirmed that his resignation stems solely from these new obligations and involves no disagreements with Cencora regarding operations or policies. The company acknowledged his dedicated service. Cencora operates in the pharmaceutical distribution industry.

Cencora disclosed that beginning July 1, 2026, certain Walgreens volume previously serviced separately from the prime vendor agreement began moving outside the Company. The company clarified that this transition was fully anticipated in its August 5, 2026 commentary regarding fourth-quarter expectations for its U.S. Healthcare Solutions segment and reaffirmed its adjusted diluted EPS guidance range of $17.75 to $17.95 for fiscal year 2026. Cencora operates as a wholesale distributor of pharmaceuticals and healthcare products.

On July 31, 2026, Cencora, Inc. amended its Multi-Currency Revolving Credit Facility to increase aggregate commitments from $5.5 billion to $7.0 billion and extend the maturity date to July 2031. The company also reduced its Receivables Securitization Facility size from $1.5 billion to $1.0 billion while increasing the accordion feature capacity to $1.0 billion. These changes align financial covenants across facilities and provide additional liquidity for ongoing business needs. Cencora operates in the pharmaceutical distribution industry, providing supply chain management services to healthcare providers.

Cencora reported fiscal third quarter revenue of $84.8 billion, a 5.1 percent year-over-year increase, with diluted earnings per share rising to $3.94 and adjusted diluted EPS reaching $4.48. The company raised its full-year adjusted diluted EPS guidance range to $17.75–$17.95 from the previous $17.70–$17.90. Additionally, Cencora repurchased $1 billion of shares during the quarter and declared a quarterly cash dividend of $0.60 per share payable on August 31, 2026, to record holders as of August 14, 2026. The company operates in the pharmaceutical distribution and healthcare solutions industry.

Cencora, Inc. announced that Silvana Battaglia will retire as Executive Vice President and Chief Human Resources Officer effective July 12, 2026, and will remain in an advisory role through the end of 2026. Samantha L. Hammock, formerly Executive Vice President and Chief Human Resources Officer of Verizon Communications Inc., will succeed her in the role effective July 13, 2026. The company stated the retirement was not due to any disagreement regarding operations, policies, or practices. Cencora is a healthcare services company that operates as a global pharmaceutical distributor.